Journal of Acute Disease

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 10  |  Issue : 3  |  Page : 117--121

Detection of oqxA and oqxB efflux pump genes among nosocomial coliform bacilli: An observational cross-sectional study


Basant Mostafa Gabr1, Afaf Sayed Ahmed Zamzam1, Eman Ahmed Eisa1, Ghada Foad El-Baradey2, Maii Atef Shams Eldeen1,  
1 Microbiology and Immunology Department, Faculty of Medicine, Tanta University, El-Gaish, Tanta Qism 2, Tanta, Gharbia, Egypt
2 Anesthesiology and Intensive Care Department, Faculty of Medicine, Tanta University, El-Gaish, Tanta Qism 2, Tanta, Gharbia, Egypt

Correspondence Address:
Basant Mostafa Gabr
Microbiology and Immunology Department, Faculty of Medicine, Tanta University, El-Gaish, Tanta Qism 2, Tanta, Gharbia
Egypt

Abstract

Objectives: To identify and test the antibiotic susceptibility of nosocomial coliform bacilli and investigate the presence of oqxA and oqxB genes among the multidrug-resistant (MDR) phenotypes. Methods: One hundred and twenty different healthcare-associated infection samples were collected. Coliform bacilli were isolated, identified by conventional methods, and then antibiotic susceptibility tests were done using the VITEK2 system and disk diffusion methods. OqxAB operon was identified using a conventional PCR-based technique. oqxA and oqxB genes were compared between MDR Klebsiella pneumonia (K. pneumonia) phenotypes and MDR Escherichia coli (E. coli) phenotypes. Besides, oqxAB operons were compared between phenotypes of K. pneumonia and E. coli isolates. Results: Seventy coliform bacilli were isolated with the predominance of K. pneumonia and E. coli. Besides, 82.1% of K. pneumonia strains and 53.3% of E. coli isolates were MDR phenotypes. Significant more oqxB genes alone were found in MDR E. coli than that in MDR K. pneumoniae phenotypes (χ2=10.160, P=0.003). OqxAB operon was significantly more in MDR phenotypes of E. coli than that in the susceptible phenotypes (P<0.001). There was significantly less of this operon in susceptible E. coli isolates than that in susceptible K. pneumoniae isolates (P<0.001). OqxAB positive isolates that were also resistant to fluoroquinolones, tetracycline, trimethoprim, and chloramphenicol, most probably suggested functional pumps. Conclusions: MDR coliform bacilli are strongly implicated in healthcare-associated infection. Attention should be paid to the presence of oqxAB pump, as an important mechanism in the development of resistance against many antimicrobials because it contributes to co-resistance with other categories; therefore, this pump could be a good target for efflux pump inhibitors.



How to cite this article:
Gabr BM, Zamzam AS, Eisa EA, El-Baradey GF, Eldeen MA. Detection of oqxA and oqxB efflux pump genes among nosocomial coliform bacilli: An observational cross-sectional study.J Acute Dis 2021;10:117-121


How to cite this URL:
Gabr BM, Zamzam AS, Eisa EA, El-Baradey GF, Eldeen MA. Detection of oqxA and oqxB efflux pump genes among nosocomial coliform bacilli: An observational cross-sectional study. J Acute Dis [serial online] 2021 [cited 2021 Jul 30 ];10:117-121
Available from: http://www.jadweb.org/text.asp?2021/10/3/117/316676


Full Text

 1. Introduction



Coliform bacilli are among the most commonly reported Gram-negative pathogens from healthcare-associated infection (HAI)[1]. The olaquindox/quinolone AB (oqxAB) efflux pump is one of the resistant mechanisms that contribute to intrinsic, acquired, and phenotypic resistance by lowering intracellular antibiotic concentration and promoting site mutation accumulation. This pump contributes to resistance to multiple agents like detergents, disinfectants, and certain antibiotics as quinoxalines, quinolones, fluoroquinolones (FQs), trimethoprim, tetracycline, and chloramphenicol[2],[3].

This study aims to identify the nosocomial coliform bacilli from Tanta University Emergency Hospital, test their antimicrobial susceptibility patterns, and investigate the presence of oqxA and oqxB genes among resistant phenotypes.

 2. Materials and methods



2.1. Ethical approval

This study was reviewed and approved by the Ethics and Research Committee of Quality Assurance Unit, Faculty of Medicine, Tanta University, Egypt (No. 32634/10/18).

2.2. Inclusion criteria

This observational cross-sectional study was carried out on 120 different nosocomial isolates from patients who acquired HAI after admitted to Tanta University Emergency Hospital from December 2018 to December 2019. All patients whether taking antibiotics or not were subjected to thorough history taking and clinical examination to demonstrate any evidence of the commonest types of HAIs e.g. catheter-associated urinary tract infection, ventilator-associated pneumonia, central line-associated bloodstream infection, and surgical site infection according to classifications of Centers for Disease Control and Prevention[4].

2.3. Exclusion criteria

Patients incubating any infection at the time of hospital admission or revealed any isolated bacteria other than coliform bacilli were excluded.

2.4. Collection and handling of specimens

Specimens were collected, transported then stored under complete aseptic precautions[5]. Processing of samples was carried out in the Medical Microbiology and Immunology Department, Faculty of Medicine, Tanta University.

2.5. Identification of coliform bacilli isolates

Specimens were subjected to the routine protocol for identification of coliform bacilli as follows: Gram-stained smear, cultivation on Nutrient and MacConkey’s agar plates then aerobic incubation at 37 °C for 24-48 h. Moreover, urine samples were cultivated on cystine-lactose-electrolyte-deficient agar plates to determine significant bacteriuria (bacterial count exceeding 105 organisms/mL was considered significant). After overnight incubation, colonies were identified by colony morphology, Gram staining, and different biochemicals[6].

2.6. Antimicrobial susceptibility testing of coliform bacilli isolates

In the present study, two antimicrobial susceptibility testing methods were used: Kirby-Bauer disk diffusion and VITEK 2 compact system. In the disk diffusion method, the used antibiotics were the commercially available quinolones and FQs that were not included in the used VITEK card. Other antimicrobial categories associated with the oqxAB efflux pump e.g. tetracycline, chloramphenicol, and trimethoprim were also tested. The results were interpreted by measuring the diameters of inhibition zones[7].

Concerning VITEK 2 Compact system method, Gram-negative antimicrobial susceptibility testing-N233 cards for Gran-negative bacteria (BioMérieux, France) were used. All procedures were performed according to the manufacturer’s recommendations. The results interpretation was done by the VITEK 2 advanced expert system™ software.

2.7. Detection of oqxA and oqxB genes

This step was initially done in the Central Lab of Tanta University and continued in the Molecular Unit of Bacteriology, Tor Vergata University, Rome. Specific primers for each gene were prepared (Thermo Fisher Scientific co., USA) according to Kim and his colleges[8] as shown in [Table 1]. DNA was extracted from a fresh pure culture of coliform isolates by DNA extraction kit (QIAGEN) then amplification of the target genes by conventional end-point PCR and detection of the amplified genes by agarose gel electrophoresis[9].{Table 1}

2.8. Statistical analysis

Data were analyzed using Microsoft Excel 2007 and IBM SPSS software package version 20.0. Qualitative data were described by frequency and percentages. Comparisons between different groups regarding categorical variables were tested using the Chi-square test. The significant level of this study was set at α=0.05.

 3. Results



In the present study, 70 coliform isolates were identified, accounting for 58.3% of the total samples. The most predominant coliforms were K. pneumoniae and E. coli isolates which accounted for 32.5% and 25%, respectively. Only one isolate of Citrobacter freundii was identified while Enterobacter spp. were not detected in any of the collected samples.

Regarding resistance pattern, 82.1% of K. pneumonia strains and 53.3% of E. coli isolates were multidrug-resistant (MDR) (The isolate is non-susceptible to at least one agent in ≥3 antimicrobial categories) phenotypes. The results show significantly more MDR phenotypes than susceptible phenotypes (The isolate is susceptible to all tested antimicrobial categories or non-susceptible to <3 antimicrobial categories) both in K. pneumoniae and E. coli isolates (χ2=11.703, P=0.008).

It was found that 45.8% of total MDR coliform isolates had both oqxA and oqxB genes, and no significant difference was found between MDR K. pneumoniae and MDR E. coli isolates (χ2=0.042, P=0.979). The present findings revealed significantly more oqxB genes alone in MDR E. coli than that in MDR K. pneumoniae isolates (χ2=10.160, P=0.003). On the other hand, there was no significant difference in the oqxA gene alone between MDR K. pneumoniae and MDR E. coli isolates (χ2=4.356, P=0.113) [Table 2].{Table 2}

Significantly more oqxAB operons were found in susceptible phenotypes of K. pneumoniae isolates [7(100%)] than that in E. coli isolates [0(0%)] (P<0.001). Besides, E. coli isolates showed statistically significant more oqxAB operons in MDR phenotypes [15(93.7%)] than that in susceptible phenotypes [0(0%)] (P<0.001). Moreover, there was no significant difference in the presence of the operon among MDR K. pneumonia [31(96.8%)] and E. coli phenotypes [15(93.7%)] (P>0.999). Figures of agarose gel electrophoresis showing oqxA and oqxB genes in MDR K. pneumoniae and E. coli isolates. Size of the amplified product of oqxA genes is at 392 bp and 512 bp for oqxB genes [Figure 1].{Figure 1}

[INLINE:1]

In the trial to investigate the functionality of the oqxAB efflux pump, we correlated the presence of oqxAB operon and the phenotypic resistance to all antimicrobial agents associated with this pump together (FQs, trimethoprim, tetracycline, and chloramphenicol). We found that 90.3% of oqxAB positive K. pneumoniae and 46.6% of oqxAB positive E. coli isolates were resistant to all four associated classes of antibiotics with a statistically significant higher rate in K. pneumoniae isolates (P=0.002).

 4. Discussion



Progressive increase of MDR Gram-negative pathogens in hospitals augments the burden of HAIs globally. Thus, it is necessary to determine different resistance patterns properly and understand their mechanisms to fight this threat.

In the present study, coliform bacilli isolates accounted for 58.3% of the total clinically suspected HAIs. K. pneumoniae and E. coli were the predominant isolates. This could be explained by that they are members of our microbiome and can easily cause infections in hospitalized patients as an endogenous source especially in the absence of infection control measures. Similarly, other studies found that Klebsiella spp. were the most frequently isolated pathogens from HAIs[10],[11] while other studies done by Fakhr et al. found that Pseudomonas spp. predominated[12].

Regarding the resistance pattern of coliform bacilli isolates, more MDR phenotypes could be related to many factors including long duration of antibiotic therapy in hospitals, prolonged length of hospital stay, and frequent exposure to invasive procedures with the absence of effective infection control policies and procedures. Similarly, other studies detected a high rate of MDR phenotypes among K. pneumoniae and E. coli isolates from HAIs[13],[14].

It was also found that 45.8% of these MDR coliform isolates had both oqxA and oqxB genes in our study. The high presence of oqxAB operon might reflect the physiological role of these pumps in bacterial life. Another explanation of the overexpression of these genes is the inappropriate use of antimicrobial and/or disinfectant agents related to this pump. Moreover, close contact with domestic animals as dogs and cats could be a possible source for dissemination of oqxAB genes to humans as supported by another study by Zhao et al.[15].

Concerning K. pneumoniae isolates, both oqxA and oqxB genes were detected in 46.8% of MDR phenotypes. Interestingly, the operon was also present in 100% of susceptible K. pneumoniae isolates. This could be explained by being mainly chromosomally located in both resistant and sensitive phenotypes, perhaps as a reservoir for these genes, but the phenotypic difference occurs according to the level of gene expression. If oqxAB efflux pump genes were expressed at a basal level, it would produce proteins associated with important physiological functions in bacterial life whereas, the overexpression of these genes is more important in the development of resistance. This overexpression can be achieved either constitutive (by mutations) or transient (under specific conditions as exposure to substrates or antibiotics related to the efflux pump)[16]. This supports the idea that the more usage of antibiotics related to each efflux pump, induces overexpression of this pump.

Previous studies reported a similar higher incidence of oqxAB operon among K. pneumoniae isolates who found that the incidence was 100%, 92.5%, respectively[17],[18], while other studies reported a lower incidence of 74%[8].

On the other hand, only one resistant K. pneumoniae isolate had neither oqxA nor oqxB genes. This could be attributed to the actual absence of this efflux pump, which represents one of many other endogenous efflux systems in Gram-negative bacteria.

Concerning E. coli isolates, both oqxA and oqxB genes were detected in 43.7% of MDR E. coli isolates. Similarly, Liu et al. found that 42% of clinical resistant E. coli isolates were positive for both genes[19]. In contrary, other studies reported lower incidence of 6.05% and 18.07%, respectively[20],[21].

Furthermore, there were significantly more oqxAB operons among MDR over susceptible E. coli phenotypes (P<0.001). This could be explained by the that the oqxAB operon in E. coli is most probably carried on plasmids[2]. Those transmissible plasmids usually carry many other genes of bacterial resistance producing MDR phenotypes and play an important role in the dissemination of resistance by horizontal transfer in-between bacteria, especially within hospitals.

Previously, Cheng et al. established that the oqxAB efflux system is constitutively expressed when located in bacterial mobile elements like plasmids, so the expression level of the plasmid-borne oqxAB operon was higher than that of the chromosomal genes[22].

Moreover, we observed higher non-significant existence of the oqxA gene among K. pneumonia isolates with or without the oqxB gene. There were also significantly more oqxB genes alone among MDR E. coli than that in MDR K. pneumoniae isolates (P=0.003). This agreed with other studies[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20],[21],[22],[23].

Despite the presence of the two genes is necessary to form the oqxAB pump, no definite explanation of the detection of only one gene without the other one until now. This could be explained by the presence of different mutants that might not be detected by the used primers[17],[18],[19],[20],[21],[22]. Extra studies are needed to determine the significance of each gene alone. However, the presence of any of them is considered a potential reservoir for the spread of these genes.

Interestingly, Wong et al. revealed that there was a major difference between chromosomally located oqxAB operon and any other chromosomal efflux pump genes, as it can become plasmid-borne via transposition events, during which the oqxAB genes become overexpressed, most probably because of loss of inhibition by the oqxR repressor. Moreover, they cleared that the expression level of the plasmid-borne oqxAB operon was >80 fold of the chromosomal genes[24].

In this study, a trial was done to investigate the functionality of this pump by correlating between the presence of oqxAB pump genes and resistance to certain antimicrobial agents associated with the oqxAB pump (FQs, tetracycline, chloramphenicol, and trimethoprim). It was found that 90.3% of K. pneumoniae and 46.6% of E. coli isolates containing oqxAB operon were resistant to all the four tested classes of antibiotics. We suggest that oqxAB positive isolates together with resistance to the four tested antibiotics is most probably an indication of the functioning pump, and those isolates are good targets to be tested with efflux pump inhibitors in a trial to be used as an antimicrobial adjuvant or alternative. This opinion was supported by other studies[15],[16],[17],[18],[19].

Still, there were some limitations to this study, for instance, we could not determine whether oqxAB operon was located on plasmids or chromosomes, as more profound molecular techniques are needed to analyze the locations of these oqxAB operons.

 5. Conclusions



In conclusion, MDR coliform bacilli particularly K. pneumoniae and E. coli are seriously involved in various types of HAIs. Although MDR oqxAB efflux pumps are mainly chromosomally located in Klebsiella spp, they are increasingly disseminating in-between nosocomial MDR coliform bacilli. This efflux pump mediates co-resistance with other antimicrobial categories e.g. FQs, tetracycline, chloramphenicol, and trimethoprim. For practical guidance, the presence of oqxAB operon and phenotypic resistance to other associated antibiotics can be used as good evidence of the expression of these genes and the functionality of this pump. Further studies are needed, as trials, to use oqxAB efflux pump inhibitors that can be promising in the treatment of MDR pathogens as an adjuvant or an alternative to antimicrobial agents.

Conflict of interest statement

The authors report no conflict of interest.

Acknowledgments

We thank Dr. Marco Favaro (Head of Molecular Unit of Microbiology, Department of Experimental Medicine, Tor Vergata University, Rome, Italy) for his generous guidance, valuable supervision, and for giving the candidate (the corresponding author) the chance to practice the molecular work in his laboratory.

Authors’ contributions

All authors contributed equally to this article.

References

1Chen IL, Lee CH, Su LH, Tang YF, Chang SJ, Liu JW. Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant Gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship. PloS One 2013; 8(5): e65621.
2Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, et al. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control 2019; 8(1): 1-3.
3Hansen LH, Jensen LB, Sørensen HI, Sørensen SJ. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 2007; 60(1): 145-147.
4Centers for Disease Control and Prevention (CDC) 2020. Classifications of Centers for Disease Control and Prevention. [Online] Available from: https://www.cdc.gov. [Accessed on 10 th December 2020].
5Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67(6): e1-e94.
6Jacobson SA. Enterobacteriaceae. In: Bailey & Scott’s diagnostic microbiology. 14th ed. St. Louis, Missouri: Elsevier; 2017. p. 329-354.
7Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Thirty Informational Supplement. M100S 30th ed. [Online] Available from: https://clsi.org/ media/3481/m100ed30_sample.pdf. [Accessed on10th December 2020].
8Kim HB, Wang MH, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53(8): 3582-3584.
9Rodríguez-Martínez JM, Díaz de Alba P, Briales A, Machuca J, Lossa M, Fernández-Cuenca F, et al. Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother 2013; 68(1): 68-73.
10Elwakil BH, Ali SM, Hafez SF, Bekhit AA, El-Naggar MY, Olama ZA. Resistance prevalence profile of Klebsiella pneumoniae in the Intensive Care Units of Al-Shatby Pediatric Hospital, Alexandria, Egypt. Novel Res Microbiol J 2019; 3(6): 535-545.
11Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 2016; 37(11): 1288-1301.
12Fakhr AE, Fathy FM. Bacterial pattern and risk factors of hospital acquired infections in a tertiary care hospital, Egypt. Egypt J Med Microbiol 2018; 27(1): 9-16.
13Taha SA, Omar HH. Characterization of plasmid-mediated qnrA and qnrB genes among Enterobacteriaceae strains: quinolone resistance and ESBL production in Ismailia, Egypt. Egypt J Med Hum Genet 2019; 20(1): 1-7.
14Bitew A, Tsige E. High prevalence of multidrug-resistant and extended-spectrum β-lactamase-producing enterobacteriaceae: A cross-sectional study at Arsho advanced medical laboratory, Addis Ababa, Ethiopia. J Trop Med 2020; 2020: 6167234.
15Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W, et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother 2010; 54(10): 4219-4224.
16Maurya N, Jangra M, Tambat R, Nandanwar H. Alliance of efflux pumps with β-Lactamases in multidrug-resistant Klebsiella pneumoniae isolates. Microb Drug Resist 2019; 25(8): 1155-1163.
17Yuan J, Xu X, Guo Q, Zhao X, Ye X, Guo Y, et al. Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. J Antimicrob Chemother 2012; 67(7): 1655-1659.
18Hamed SM, Aboshanab KM, El-Mahallawy HA, Helmy MM, Ashour MS, Elkhatib WF. Plasmid-mediated quinolone resistance in gram-negative pathogens isolated from cancer patients in Egypt. Microb Drug Resist 2018; 24(9): 1316-1325.
19Liu B, Wu H, Zhai Y, He Z, Sun H, Cai T, et al. Prevalence and molecular characterization of oqxAB in clinical Escherichia coli isolates from companion animals and humans in Henan Province, China. Antimicrob Resist Infect Control 2018; 7(1): 1-9.
20Kao CY, Wu HM, Lin WH, Tseng CC, Yan JJ, Wang MC, et al. Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001-2015. Sci Rep 2016; 6(1): 1-8.
21Wang J, Guo ZW, Zhi CP, Yang T, Zhao JJ, Chen XJ, et al. Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 2017; 72(5): 1293-1302.
22Cheng L, Cao XL, Zhang ZF, Ning MZ, Xu XJ, Zhou W, et al. Clonal dissemination of KPC-2 producing Klebsiella pneumoniae ST11 clone with high prevalence of oqxAB and rmtB in a tertiary hospital in China: results from a 3-year period. Ann Clin Microbiol Antimicrob 2016; 15(1): 1-8.
23El-Badawy MF, Tawakol WM, El-Far SW, Maghrabi IA, Al-Ghamdi SA, Mansy MS, et al. Molecular identification of aminoglycoside-modifying enzymes and plasmid-mediated quinolone resistance genes among Klebsiella pneumoniae clinical isolates recovered from Egyptian patients. Int J Microbiol 2017; 2017: 8050432.
24Wong MH, Chan EW, Chen S. Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother 2015; 59(6): 3290-3297.